Alfonso Quintas Cardama - Net Worth and Insider Trading
Alfonso Quintas Cardama Net Worth
The estimated net worth of Alfonso Quintas Cardama is at least $182,422 dollars as of 2024-05-10. Alfonso Quintas Cardama is the Chief Medical Officer of TCR2 Therapeutics Inc and owns about 123,258 shares of TCR2 Therapeutics Inc (TCRR) stock worth over $182,422. Details can be seen in Alfonso Quintas Cardama's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alfonso Quintas Cardama has not made any transactions after 2022-12-13 and currently still holds the listed stock(s).
Transaction Summary of Alfonso Quintas Cardama
Alfonso Quintas Cardama Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alfonso Quintas Cardama owns 2 companies in total, including TCR2 Therapeutics Inc (TCRR) , and Foghorn Therapeutics Inc (FHTX) .
Click here to see the complete history of Alfonso Quintas Cardama’s form 4 insider trades.
Insider Ownership Summary of Alfonso Quintas Cardama
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRR | TCR2 Therapeutics Inc | 2022-12-13 | Chief Medical Officer |
| FHTX | Foghorn Therapeutics Inc | 2023-09-11 | Chief Medical Officer |
Alfonso Quintas Cardama Latest Holdings Summary
Alfonso Quintas Cardama currently owns a total of 1 stock. Alfonso Quintas Cardama owns 123,258 shares of TCR2 Therapeutics Inc (TCRR) as of December 13, 2022, with a value of $182,422.
Latest Holdings of Alfonso Quintas Cardama
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRR | TCR2 Therapeutics Inc | 2022-12-13 | 123,258 | 1.48 | 182,422 |
Holding Weightings of Alfonso Quintas Cardama
Alfonso Quintas Cardama Form 4 Trading Tracker
According to the SEC Form 4 filings, Alfonso Quintas Cardama has made a total of 4 transactions in TCR2 Therapeutics Inc (TCRR) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in TCR2 Therapeutics Inc is the sale of 13,799 shares on December 13, 2022, which brought Alfonso Quintas Cardama around $15,179.
Insider Trading History of Alfonso Quintas Cardama
- 1
Alfonso Quintas Cardama Trading Performance
Alfonso Quintas Cardama Ownership Network
Alfonso Quintas Cardama Owned Company Details
What does TCR2 Therapeutics Inc do?
Who are the key executives at TCR2 Therapeutics Inc?
Alfonso Quintas Cardama is the Chief Medical Officer of TCR2 Therapeutics Inc. Other key executives at TCR2 Therapeutics Inc include 10 percent owner Kevin C Tang , director & 10 percent owner Ansbert Gadicke , and 10 percent owner Mpm Asset Management Llc .
TCR2 Therapeutics Inc (TCRR) Insider Trades Summary
Over the past 18 months, Alfonso Quintas Cardama made 4 insider transaction in TCR2 Therapeutics Inc (TCRR) with a net sale of 32,841. Other recent insider transactions involving TCR2 Therapeutics Inc (TCRR) include a net purchase of 468,513 shares made by Kevin C Tang , a net sale of 82,187 shares made by Garry E Menzel , and a net sale of 20,524 shares made by Angela Justice .
In summary, during the past 3 months, insiders sold 0 shares of TCR2 Therapeutics Inc (TCRR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 287,401 shares of TCR2 Therapeutics Inc (TCRR) were sold and 468,513 shares were bought by its insiders, resulting in a net purchase of 181,112 shares.
TCR2 Therapeutics Inc (TCRR)'s detailed insider trading history can be found in Insider Trading Tracker table.
TCR2 Therapeutics Inc Insider Transactions
Alfonso Quintas Cardama Mailing Address
Above is the net worth, insider trading, and ownership report for Alfonso Quintas Cardama. You might contact Alfonso Quintas Cardama via mailing address: C/o Tcr2 Therapeutics Inc., 100 Binney Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
